Sex-related differences in atrophy and lesion load in multiple sclerosis patients;Diferencias en la tasa de atrofia global y regional y del volumen lesional entre género en esclerosis múltiple

Neurologia

Volumn 28, Issue 7, 2013, Pages 389-393

  Rojas, J I ^a   Patrucco, L ^a   Besada, C ^a   Funes, J ^a   Cristiano, E ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Brain atrophy; Multiple sclerosis; Structural Image Evaluation Normalization Atrophy regional; Structural image evaluation using normalisation of atrophy

Indexed keywords

ARGENTINA; ARTICLE; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; FRONTAL CORTEX; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SEX DIFFERENCE; WHITE MATTER;

ATROFIA CEREBRAL; BRAIN ATROPHY; ESCLEROSIS MÚLTIPLE; MULTIPLE SCLEROSIS; STRUCTURAL IMAGE EVALUATION NORMALIZATION ATROPHY REGIONAL; STRUCTURAL IMAGE EVALUATION USING NORMALISATION OF ATROPHY;

ADULT; ARGENTINA; ATROPHY; BRAIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84883782080     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2012.10.008     Document Type: Article

References (20)

1. Di Filippo M., Anderson V.M., Altmann D.R., Swanton J.K., Plant G.T., Thompson A.J., et al. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2010, 81:204-208.
2. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359:1221-1231.
3. Noseworthy J.H., Lucchinetti C., Rodríguez M., Weinshenker B.G. Multiple sclerosis. N Engl J Med 2000, 343:938-952.
4. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998, 339:285-291.
5. Horakova D., Cox J.L., Havrdova E., Hussein S., Dolezal O., Cookfair D., et al. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. J Neurol Neurosurg Psychiatry 2008, 79:407-414.
6. Vukusic S., Confavreux C. Natural history of multiple sclerosis: risk factors and prognostic indicators. Curr Opin Neurol 2007, 20:269-274.
7. Pozzilli C., Tomassini V., Marinelli F., Paolillo A., Gasperini C., Bastianello S. "Gender gap" in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 2003, 10:95-97.
8. Filippi M., Rocca M.A. Novel MRI approaches to assess patients with multiple sclerosis. Curr Opin Neurol 2010, 23:212-217.
9. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231.
10. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
11. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria. Ann Neurol 2005, 58:840-846.
12. Miller D., Barkhof F., Montalban X., Thompson A., Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part i: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005, 4:281-288.
13. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002, 17:479-489.
14. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001, 20:45-57.
15. Smith S.M., de Stefano N., Jenkinson M., Matthews P.M. Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001, 25:466-475.
16. Antulov R., Weinstock-Guttman B., Cox J.L., Hussein S., Durfee J., Caiola C., et al. Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Mult Scler 2009, 15:345-354.
17. Peeva E., Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005, 101:123-143.
18. Kanda N., Tsuchida T., Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:1703-1711.
19. Sicotte N.L., Giesser B.S., Tandon V., Klutch R., Steiner B., Drain A.E., et al. Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 2007, 64:683-688.
20. Patwardhan A.J., Eliez S., Bender B., Linden M.G., Reiss A.L. Brain morphology in Klinefelter syndrome: extra X chromosome and testosterone supplementation. Neurology 2000, 54:2218-2223.